Bill Cance

Cancer surgeon, scientist and champion of research innovation. Lover of all things jazz and gardening.

[GRAIL @GrailBio]

We’re initiating a real-world study to evaluate the clinical impact of #MCED screening among Medicare beneficiaries.

Learn more here: https://t.co/TRfWMsXlUq

Please see enclosed video providing a study overview: https://t.co/czEGxzP8m3

[GRAIL @GrailBio]

This past weekend at #AACRDisp23, our team presented data on multi-cancer early detection across races and ethnicities and how it can address socioeconomic disparities in receipt of cancer screening.

[GRAIL @GrailBio]

GRAIL has been named on @FortuneMagazine's 2023 #ChangeTheWorld list. This accomplishment is only possible due to the steadfast dedication of our employees, who are working together every day to redefine the status quo of cancer detection. Read more: https://t.co/X1tWPJQX87

[GRAIL @GrailBio]

In the latest episode of our podcast #TheCancerSignal, @AICAF_Org CEO Melissa Buffalo delves into why Indigenous communities face disparities in cancer screening and care, and what can be done to address this.

🎙️Listen here: https://t.co/6QtTV88ikf

[GRAIL @GrailBio]

Today we announced a new research collaboration with @whitmanwalker and @cancersupporthq that will evaluate multi-cancer early detection screening to increase cancer detection in underserved populations.

Learn more: https://t.co/WmuQpgx3rN

[GRAIL @GrailBio]

At #ASCO23, GRAIL and @OxfordOncology will present results from SYMPLIFY, which show strong performance of multi-cancer early detection testing in people presenting with non-specific symptoms.

Learn about the exciting potential of this analysis: https://t.co/vvnyb5RcDU

[The Wall Street Journal @WSJ]

New blood tests that screen for risks of cancer and Alzheimer’s provide more information—but what do you do with that information? https://t.co/FjdzTtBktb

[Bill Cance @BillCance]

Great panel discussion today. So important to obtain high quality RWD that is regulatory-grade. Thanks for a superb job moderating, Peter!

[Peter WT Pisters, MD @ppisters]

Great to be with @LhPeng, @BillCance and @DavidAgus at today's @NixonFoundation Tech in Medicine Panel. Enjoyed moderating a superb discussion on the impact of quality and real world data, patient inclusion, and talent dependencies to advance medicine. Thanks for having me!

[Bill Cance @BillCance]

So proud of the depth of science that underpins our transformational multi-cancer early detection test. The translational impact for patients is only beginning!

[GRAIL @GrailBio]

Findings from a fundamental substudy evaluating different approaches to multi-cancer early detection have been published in @Cancer_Cell. Learn how the results informed the development of our multi-cancer early detection test. https://t.co/YYi2k0BsVh

[GRAIL @GrailBio]

We’re honored to have @GalleriTest included in TIME’s Best Inventions of 2022 list! #TIMEBestInventions https://t.co/4gYG53CN3V

[Bill Cance @BillCance]

Delighted to join our @ACSCAN and @AmericanCancer partners to move our efforts at earlier cancer detection forward!!

[Lisa Lacasse @LLacasseACSCAN]

Thrilled to join our strategic partner ⁦@GrailBio⁩ while in CA. Their “wall of hope” provides inspiration and urgency to ⁦@ACSCAN⁩ & ⁦@AmericanCancer⁩ shared mission of detecting cancers earlier.

[ACS Journal Cancer @JournalCancer]

#OpenAccess in the Oct 1 issue | Older age and smoking were the two most important risk factors associated with the relative and absolute 5-year risk of developing any cancer https://t.co/49eyFdjegp @AlpaVPatel @BillCance @ACS_Research

[Prevent Cancer Foundation @preventcancer]

“We’re losing 600,000 Americans every year to this dreaded disease. But, together with the leadership of organizations like @preventcancer & the legislators being honored tonight, we can take a critical step toward ending the scourge of cancer.” - @DrJoshuaOfman @GrailBio

[Bill Cance @BillCance]

Great to see Dr Jacqueline Jeruss from ⁦@UMich⁩ at the ⁦@AmerSurg⁩ meeting! ⁦@ACS_Research⁩ helped launch her career and now her daughter, Sydney, is supporting #researcHERS! https://t.co/kjPQCRKEwG ⁦@sandralwong⁩

[Alpa Patel @AlpaVPatel]

Congratulations to Dr. Sue Hankinson for winning the AACR-American Cancer Society award for Research Excellence in Cancer Epidemiology and Prevention @aacr #AACR2022 @AmerCancerCMSO @AmericanCancer

[Nicole Lopanik @lopanik]

Great news for B-cell lymphoma patients! @AmericanCancer and @ACS_Research supports research in B-cell lymphoma and CAR T-cell treatment to help develop more effective therapies. https://t.co/GFaW0xZoXE

[Bill Cance @BillCance]

Great to see FDA approval of the 1st targeted radiotherapy for advanced #ProstateCancer. @ACS_Research is committed to reducing PrCa burden, funding 65 PrCa grants ($26.3M) at 52 different institutions in the past 5 yrs with 18 focused on PrCa metastasis https://t.co/h9Exb33Ye7

[Bill Cance @BillCance]

Terrific work returning people to cancer screening presented by @RachelJoung_MD at the Cancer Programs meeting today.Proud of collaboration between @AmCollSurgeons Cancer Programs and @AmericanCancer. Leveraging our strengths to amplify successes & generate metrics for next steps

[Sarah Shafir @smshafir]

American Cancer Society joins Commission on Cancer in their 100 year celebration of bringing quality cancer care to patients and their families. @kathyhgoss @AmerCancerCMSO @AmericanCancer

[CA: A Cancer Journal for Clinicians @CACancerJournal]

Regular physical activity & a healthy diet are 2 of the most important modifiable factors in long-term health for #CancerSurvivors. 🍅���⛹️‍♀️🏊‍♂️

Share this #infographic with your patients & access the latest recommendations from @AmericanCancer here: https://t.co/zUgAg3tA3i